Solid Biosciences Inc.

SLDB · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances) · Market Cap: $0.7B · 121 employees
132
SEC Filings
$5.81
Close 2026-10-26
121
Employees

Business Summary

Solid Biosciences Inc. is a life sciences company focused on developing gene therapy candidates for rare neuromuscular and cardiac diseases. Its pipeline includes SGT-003 for Duchenne muscular dystrophy, SGT-212 for Friedreich's ataxia, SGT-501 for CPVT, and SGT-601 for TNNT2-mediated dilated cardiomyopathy. The company uses AAV-based gene transfer technology, proprietary capsids (including POLARIS-101), and optimized expression cassettes. SGT-003 is in active Phase 1/2 and Phase 3 clinical trials.

Latest Stock Quote

SLDB 2026-10-26 $5.81 O:$6 H:$6.09 L:$5.74 Vol:1.1M VWAP:$5.838
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-28

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-192025-12-310001193125-26-115928EDGAR115K words
2025-03-062024-12-310000950170-25-034644EDGAR127K words
2024-03-132023-12-310000950170-24-030508EDGAR110K words
2023-03-232022-12-310000950170-23-009318EDGAR107K words
2022-03-142021-12-310001564590-22-009963EDGAR127K words
2021-03-152020-12-310001564590-21-013153EDGAR125K words
2020-03-122019-12-310001564590-20-010247EDGAR113K words
2019-03-132018-12-310001564590-19-007462EDGAR110K words
2018-03-292017-12-310001193125-18-100742EDGAR111K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-11-042026-09-300001193125-26-447178EDGAR71K words
2026-08-062026-06-300001193125-26-337935EDGAR70K words
2025-11-032025-09-300001193125-25-262818EDGAR70K words
2025-08-122025-06-300000950170-25-107279EDGAR68K words
2025-05-152025-03-310000950170-25-072560EDGAR64K words
2024-11-062024-09-300000950170-24-122247EDGAR68K words
2024-08-132024-06-300000950170-24-096130EDGAR65K words
2024-05-152024-03-310000950170-24-060034EDGAR62K words
2023-11-082023-09-300000950170-23-061096EDGAR65K words
2023-08-142023-06-300000950170-23-042371EDGAR67K words
2023-05-112023-03-310000950170-23-020851EDGAR65K words
2022-11-102022-09-300000950170-22-024163EDGAR70K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-08-060001193125-26-338438EDGAR1K words
2026-03-120001193125-26-102489EDGAR2K words
2026-03-060001193125-26-096709EDGAR17K words
2025-11-030001193125-25-262795EDGAR5K words
2025-06-130000950170-25-086215EDGAR1K words
2025-05-150000950170-25-072792EDGAR1K words
2025-02-180001193125-25-028691EDGAR1K words
2025-02-180001193125-25-028146EDGAR1K words
2025-02-180001193125-25-028123EDGAR4K words
2024-06-110001193125-24-159143EDGAR1K words

132 total filings indexed. 101 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

rare-neuromuscular-diseases rare-genetic-cardiac-diseases gene-therapy pediatric-rare-diseases adeno-associated-virus-(aav)-gene-transfer ck8-muscle-specific-promoter-cassette good-manufacturing-practices-(gmp) investigational-new-drug-(ind)-application-process

Company Identity

CIK0001707502
TickerSLDB
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE
Websitehttps://www.solidbio.com
Listed2018-01-25

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 58ee20d23040934be5ffcaccbb2f19654d871ac4f6445ffbf7c8e87efa323721
parent: 587bba33d62a64a5d778724b4d56abcca0e7e34c2becc85883c3318064fa6089
content hash: 10dd0fae3b9f3b730c4ab4c1237ab90be0654d140cca99391408080ccd277df9
signed: 2026-11-16T19:04:47.764Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up SLDB using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on SLDB, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/SLDB (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.